» Articles » PMID: 31632265

Free Water in White Matter Differentiates MCI and AD From Control Subjects

Overview
Specialty Geriatrics
Date 2019 Oct 22
PMID 31632265
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Recent evidence shows that neuroinflammation plays a role in many neurological diseases including mild cognitive impairment (MCI) and Alzheimer's disease (AD), and that free water (FW) modeling from clinically acquired diffusion MRI (DTI-like acquisitions) can be sensitive to this phenomenon. This FW index measures the fraction of the diffusion signal explained by isotropically unconstrained water, as estimated from a bi-tensor model. In this study, we developed a simple but powerful whole-brain FW measure designed for easy translation to clinical settings and potential use as a priori outcome measure in clinical trials. These simple FW measures use a "safe" white matter (WM) mask without gray matter (GM)/CSF partial volume contamination ( ) near ventricles and sulci. We investigated if FW inside the mask, including and excluding areas of white matter damage such as white matter hyperintensities (WMHs) as shown on T2 FLAIR, computed across the whole white matter could be indicative of diagnostic grouping along the AD continuum. After careful quality control, 81 cognitively normal controls (NC), 103 subjects with MCI and 42 with AD were selected from the ADNIGO and ADNI2 databases. We show that MCI and AD have significantly higher FW measures even after removing all partial volume contamination. We also show, for the first time, that when WMHs are removed from the masks, the significant results are maintained, which demonstrates that the FW measures are not just a byproduct of WMHs. Our new and simple FW measures can be used to increase our understanding of the role of inflammation-associated edema in AD and may aid in the differentiation of healthy subjects from MCI and AD patients.

Citing Articles

Free Water as a Marker of Early Small Vessel Disease in Healthy Aging.

Leitner M, Pirpamer L, Hofer E, Ropele S, Pasternak O, Schmidt R Eur J Neurol. 2025; 32(3):e70094.

PMID: 40040357 PMC: 11880618. DOI: 10.1111/ene.70094.


Distinguishing Early from Late Mild Cognitive Impairment Using Magnetic Resonance Free-Water Diffusion Tensor Imaging.

Bergamino M, McElvogue M, Stokes A, Alzheimers Disease Neuroimaging Initiative NeuroSci. 2025; 6(1.

PMID: 39846567 PMC: 11755477. DOI: 10.3390/neurosci6010008.


Brain microstructure alterations in subjective cognitive decline: a multi-component T2 relaxometry study.

Rivas-Fernandez M, Bouhrara M, Canales-Rodriguez E, Lindin M, Zurron M, Diaz F Brain Commun. 2025; 7(1):fcaf017.

PMID: 39845734 PMC: 11752640. DOI: 10.1093/braincomms/fcaf017.


Advancements in Immunity and Dementia Research: Highlights from the 2023 AAIC Advancements: Immunity Conference.

Kloske C, Mahinrad S, Barnum C, Batista A, Bradshaw E, Butts B Alzheimers Dement. 2024; 21(1):e14291.

PMID: 39692624 PMC: 11772715. DOI: 10.1002/alz.14291.


Free-water: A promising structural biomarker for cognitive decline in aging and mild cognitive impairment.

Sathe A, Yang Y, Schilling K, Shashikumar N, Moore E, Dumitrescu L Imaging Neurosci (Camb). 2024; 2:1-16.

PMID: 39512598 PMC: 11540062. DOI: 10.1162/imag_a_00293.


References
1.
Chad J, Pasternak O, Salat D, Chen J . Re-examining age-related differences in white matter microstructure with free-water corrected diffusion tensor imaging. Neurobiol Aging. 2018; 71:161-170. PMC: 6179151. DOI: 10.1016/j.neurobiolaging.2018.07.018. View

2.
de la Monte S . Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease. Ann Neurol. 1989; 25(5):450-9. DOI: 10.1002/ana.410250506. View

3.
Cousineau M, Jodoin P, Morency F, Rozanski V, GrandMaison M, Bedell B . A test-retest study on Parkinson's PPMI dataset yields statistically significant white matter fascicles. Neuroimage Clin. 2017; 16:222-233. PMC: 5547250. DOI: 10.1016/j.nicl.2017.07.020. View

4.
Burns J, Church J, Johnson D, Xiong C, Marcus D, Fotenos A . White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease. Arch Neurol. 2005; 62(12):1870-6. DOI: 10.1001/archneur.62.12.1870. View

5.
Kantarci K, Petersen R, Boeve B, Knopman D, Weigand S, OBrien P . DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology. 2005; 64(5):902-4. PMC: 2771335. DOI: 10.1212/01.WNL.0000153076.46126.E9. View